U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H28N2O2.H3O4P
Molecular Weight 450.4651
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANILERIDINE PHOSPHATE

SMILES

OP(O)(O)=O.CCOC(=O)C1(CCN(CCC2=CC=C(N)C=C2)CC1)C3=CC=CC=C3

InChI

InChIKey=FLQCEKVTYABVSH-UHFFFAOYSA-N
InChI=1S/C22H28N2O2.H3O4P/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18;1-5(2,3)4/h3-11H,2,12-17,23H2,1H3;(H3,1,2,3,4)

HIDE SMILES / InChI

Molecular Formula H3O4P
Molecular Weight 97.9952
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C22H28N2O2
Molecular Weight 352.4699
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Aniledrine is a narcotic pain reliver. The drug was prescribed as an analgesic in anaesthesia (Leritine brand name), however, it is no longer available on the market. Although the exact mechanism is not fully understood, aniledrine appears to elicit its action by binding to endorphine receptors in CNS.

Originator

Curator's Comment: # Merck

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
LERITINE

Approved Use

Unknown
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
5%
ANILERIDINE unknown
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
450 mg multiple, oral (total daily dose|max)
Studied dose
Dose: 450 mg
Route: oral
Route: multiple
Dose: 450 mg
Sources: Page: p.319
unhealthy, 41
n = 1
Health Status: unhealthy
Condition: Pain
Age Group: 41
Sex: M
Population Size: 1
Sources: Page: p.319
Disc. AE: Delirium...
AEs leading to
discontinuation/dose reduction:
Delirium
Sources: Page: p.319
AEs

AEs

AESignificanceDosePopulation
Delirium Disc. AE
450 mg multiple, oral (total daily dose|max)
Studied dose
Dose: 450 mg
Route: oral
Route: multiple
Dose: 450 mg
Sources: Page: p.319
unhealthy, 41
n = 1
Health Status: unhealthy
Condition: Pain
Age Group: 41
Sex: M
Population Size: 1
Sources: Page: p.319
PubMed

PubMed

TitleDatePubMed
Contact dermatitis to anileridine.
1980 Dec
Qualitative differences in effects of opioids in man: preliminary evidence for multiple mechanisms of analgesic action.
1986 May
Anileridine-induced delirium.
1995 May
Electronic-topological study of the structure-activity relationships in a series of piperidine morphinomimetics.
2002 Aug
Metabolic fate of orally administered phyllodulcin in rats.
2004 Sep
Synthesis, characterization and antimicrobial properties of a Co(II)-phthalylsulfathiazolate complex.
2010 Dec
Patents

Patents

Sample Use Guides

Aniledrine is administred either orally (in form of hydrochloride salt)
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 04:48:03 UTC 2023
Edited
by admin
on Sat Dec 16 04:48:03 UTC 2023
Record UNII
3584484N8V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANILERIDINE PHOSPHATE
MART.   ORANGE BOOK   WHO-DD  
Common Name English
Anileridine phosphate [WHO-DD]
Common Name English
ANILERIDINE PHOSPHATE [ORANGE BOOK]
Common Name English
ANILERIDINE PHOSPHATE [MART.]
Common Name English
LERITINE PHOSPHATE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C241
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
NCI_THESAURUS C1506
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
Code System Code Type Description
CAS
1976-75-6
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
NON-SPECIFIC STOICHIOMETRY
SMS_ID
100000085183
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
EPA CompTox
DTXSID801027378
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
CAS
4268-37-5
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
FDA UNII
3584484N8V
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
ChEMBL
CHEMBL1201347
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
NCI_THESAURUS
C87352
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
DRUG BANK
DBSALT001390
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
MESH
C100232
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
PUBCHEM
16051989
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
EVMPD
SUB00533MIG
Created by admin on Sat Dec 16 04:48:03 UTC 2023 , Edited by admin on Sat Dec 16 04:48:03 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY